Found: 19
Select item for more details and to access through your institution.
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 2919, doi. 10.3390/ijms23062919
- By:
- Publication type:
- Article
Diffuse large B-cell lymphoma presenting with central pontine myelinolysis: a case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Diffuse large B-cell lymphoma presenting with central pontine myelinolysis: a case report.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Tumour‐derived exosomes promote the induction of monocytic myeloid‐derived suppressor cells from peripheral blood mononuclear cells by delivering miR‐106a‐5p and miR‐146a‐5p in multiple myeloma.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 3, p. 426, doi. 10.1111/bjh.19049
- By:
- Publication type:
- Article
Lenalidomide and pomalidomide potently interfere with induction of myeloid‐derived suppressor cells in multiple myeloma.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 784, doi. 10.1111/bjh.16881
- By:
- Publication type:
- Article
Sequential therapy of four cycles of bortezomib, melphalan, and prednisolone followed by continuous lenalidomide and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Toxic epidermal necrolysis in adult T cell leukemia/lymphoma treated with mogamulizumab.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Aberrant BUB1 Overexpression Promotes Mitotic Segregation Errors and Chromosomal Instability in Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2206, doi. 10.3390/cancers12082206
- By:
- Publication type:
- Article
Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3134, doi. 10.1002/cam4.5237
- By:
- Publication type:
- Article
Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 5185, doi. 10.1002/cam4.3136
- By:
- Publication type:
- Article
Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature.
- Published in:
- Infection & Drug Resistance, 2022, v. 15, p. 2723, doi. 10.2147/IDR.S360238
- By:
- Publication type:
- Article
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 697, doi. 10.1007/s12185-024-03750-y
- By:
- Publication type:
- Article
Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 1, p. 50, doi. 10.1007/s12185-023-03680-1
- By:
- Publication type:
- Article
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
EWSR1 overexpression is a pro-oncogenic event in multiple myeloma.
- Published in:
- International Journal of Hematology, 2021, v. 113, n. 3, p. 381, doi. 10.1007/s12185-020-03027-0
- By:
- Publication type:
- Article
Toward further simplification of elotuzumab therapy by subcutaneous administration.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 9, p. 1724, doi. 10.3390/diagnostics11091724
- By:
- Publication type:
- Article
miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma.
- Published in:
- Cancer Science, 2024, v. 115, n. 2, p. 452, doi. 10.1111/cas.16027
- By:
- Publication type:
- Article
Triple targeting of RSK, AKT, and S6K as pivotal downstream effectors of PDPK1 by TAS0612 in B‐cell lymphomas.
- Published in:
- Cancer Science, 2023, v. 114, n. 12, p. 4691, doi. 10.1111/cas.15995
- By:
- Publication type:
- Article